Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
- Thaçi, D.
- Blauvelt, A.
- Reich, K.
- Tsai, T.-F.
- Vanaclocha, F.
- Kingo, K.
- Ziv, M.
- Pinter, A.
- Hugot, S.
- You, R.
- Milutinovic, M.
ISSN: 1097-6787, 0190-9622
Year of publication: 2015
Volume: 73
Issue: 3
Pages: 400-409
Type: Article